Shalini Vijayakumar

Immunogenicity and safety of homologous and heterologous booster vaccination of ChAdOx1 nCoV-19 (COVISHIELD™) and BBV152 (COVAXIN®): a non-inferiority phase 4, participant and observer-blinded, randomised study

G. Kang, S. Babji, A. George, 2023, The Lancet Regional Health - Southeast Asia.